Search Results - "LENZE, D"
-
1
A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance
Published in Cancer gene therapy (01-09-2015)“…In April 2013 our group published a review on predictive molecular pathology in this journal. Although only 2 years have passed many new facts and stimulating…”
Get full text
Journal Article -
2
Differential regulation of miR-21 and miR-146a by Epstein–Barr virus-encoded EBNA2
Published in Leukemia (01-11-2012)“…The discovery of microRNA (miR) represents a novel paradigm in RNA-based regulation of gene expression and their dysregulation has become a hallmark of many a…”
Get full text
Journal Article -
3
Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma
Published in Haematologica (Roma) (01-04-2014)“…Chromosomal translocations affecting the MYC oncogene are the biological hallmark of Burkitt lymphomas but also occur in a subset of other mature B-cell…”
Get full text
Journal Article -
4
Specific T-cell receptor beta-rearrangements of gluten-triggered CD8+ T-cells are enriched in celiac disease patients' duodenal mucosa
Published in Clinical immunology (Orlando, Fla.) (01-11-2023)“…Celiac disease (CeD) is an autoimmune disorder affecting the small intestine with gluten as disease trigger. Infections including Influenza A, increase the CeD…”
Get full text
Journal Article -
5
Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing
Published in Leukemia (01-03-2018)“…Depending on disease stage follicular lymphoma (FL) lack the t(14;18) in ~15–~50% of cases. Nevertheless, most of these cases express BCL2. To elucidate…”
Get full text
Journal Article -
6
Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus
Published in Leukemia (01-04-2016)“…Approximately 15% of follicular lymphomas (FLs) lack breaks in the BCL2 locus. The aim of this study was to better define molecular and clinical features of…”
Get full text
Journal Article -
7
Cellular senescence predicts treatment outcome in metastasised colorectal cancer
Published in British journal of cancer (10-08-2010)“…Background: Cellular senescence is a terminal cell-cycle arrest that occurs in response to activated oncogenes and DNA-damaging chemotherapy. Whether cancer…”
Get full text
Journal Article -
8
The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma
Published in Leukemia (01-12-2011)“…Sporadic Burkitt lymphoma (sBL) can be delineated from diffuse large B-cell lymphoma (DLBCL) by a very homogeneous mRNA expression signature. However, it…”
Get full text
Journal Article -
9
Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma
Published in Leukemia (01-07-2015)“…Prognostically relevant risk factors in patients with diffuse large B-cell lymphoma (DLBCL) have predominantly been evaluated in elderly populations. We tested…”
Get full text
Journal Article -
10
Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas
Published in Leukemia (01-07-2007)Get full text
Journal Article -
11
-
12
-
13
Donor CD4 T Cell Diversity Determines Virus Reactivation in Patients After HLA‐Matched Allogeneic Stem Cell Transplantation
Published in American journal of transplantation (01-08-2015)“…Delayed reconstitution of the T cell compartment in recipients of allogeneic stem cell grafts is associated with an increase of reactivation of latent viruses…”
Get full text
Journal Article -
14
The metastatic cascade is reflected in the transcriptome of metastatic canine mammary carcinomas
Published in The veterinary journal (1997) (01-11-2011)“…Proliferation, dedifferentiation and loss of cell–cell contacts are amongst the first steps of the metastatic cascade. The complex molecular pathways and gene…”
Get full text
Journal Article -
15
Evidence for a role of RUNX1 as recombinase cofactor for TCRβ rearrangements and pathological deletions in ETV6-RUNX1 ALL
Published in Scientific reports (22-06-2020)“…T-cell receptor gene beta (TCRβ) gene rearrangement represents a complex, tightly regulated molecular mechanism involving excision, deletion and recombination…”
Get full text
Journal Article -
16
The IL-15 cytokine system provides growth and survival signals in Hodgkin lymphoma and enhances the inflammatory phenotype of HRS cells
Published in Leukemia (01-05-2015)Get full text
Journal Article -
17
Dose dependent molecular effects of acrylamide and glycidamide in human cancer cell lines and human primary hepatocytes
Published in Toxicology letters (27-02-2013)“…► Molecular effects of low level acrylamide exposure are not well understood. ► We analyzed gene expression after low and high dose exposure in cell lines. ►…”
Get full text
Journal Article -
18
PAX5 overexpression is not enough to reestablish the mature B-cell phenotype in classical Hodgkin lymphoma
Published in Leukemia (01-01-2014)Get full text
Journal Article -
19
Histone acetylation and DNA demethylation of B cells result in a Hodgkin-like phenotype
Published in Leukemia (01-04-2008)“…A unique feature of the tumor cells (Hodgkin/Reed-Sternberg (HRS)) of classical Hodgkin lymphoma (cHL) is the loss of their B-cell phenotype despite their…”
Get full text
Journal Article -
20
Canine Cutaneous Peripheral Nerve Sheath Tumours versus Fibrosarcomas can be Differentiated by Neuroectodermal Marker Genes in their Transcriptome
Published in Journal of comparative pathology (01-02-2013)“…The diagnostic differentiation between canine fibrosarcomas and peripheral nerve sheath tumours (PNSTs) is based on histopathological phenotype. Histological…”
Get full text
Journal Article